Probiotic Bacteria Counter Depression in Mice

Article

A species of probiotic bacteria found in some yogurt reduces stress, anxiety, and depression in mice, a new study finds.

A species of probiotic bacteria found in some yogurt reduces stress, anxiety, and depression in mice, finds a study published online this week in Proceedings of the National Academy of Sciences.

In the experiment, explains a report in Nature News, 16 healthy experimental mice were fed broth containing a strain of Lactobacillus rhamnosus and were then subjected to stress tests along with 20 healthy control mice that had been fed broth without the bacteria. While navigating a maze, the experimental mice showed greater tendency to go into open spaces, indicating that they were less anxious. When forced to swim, the experimental mice were more inclined than the control mice to struggle rather than give up.

After the stressful swim, the experimental mice had half as much of the stress hormone corticosterone as the control mice. In addition, the experimental mice had brain receptors for the neurotransmitter GABA arranged in a manner found in animals that are not depressed. When the scientists cut the vagus nerve (which carries communication between the brain and the guts) in the experimental mice, this rearrangement disappeared, indicating that the bacteria were responsible for the change.

Looking toward the future, probiotic bacteria may someday be able to play a role in reducing depression in people.

Sources

Probiotic bacteria lessens depression... [Press Release]

Friendly bacteria cheer up anxious mice [Nature News]

Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve (abstract) [Proceedings of the National Academy of Sciences]

Related Videos
How to Adequately Screen for and Treat Cognitive Decline in Primary Care
Depression Screening: Challenges and Solutions at the Primary Care Level
James R. Kilgore, DMSc, PhD, PA-C: Cognitive Decline Diagnostics
HCPLive Five at APA 2024 | Image Credit: HCPLive
John M. Oldham, MD: A History of Personality Disorder Pathology
Franklin King, MD: Psychedelic Therapy History, Advances, and Hurdles
Robert Weinrieb, MD: Psychiatry-Hepatology Approach for Alcohol-Related Liver Disease
Etienne Sibille, PhD: Innovations in Cognitive Pathology
Katharine Phillips, MD: Various Treatments for Obsessive-Compulsive Disorders
Manish Jha, MD: Treatment Options for Treatment-Resistant Depression
© 2024 MJH Life Sciences

All rights reserved.